DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vinorelbine (Vinorelbine) - Neutropenic Sepsis - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Neutropenic Sepsis (21)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vinorelbine where reactions include neutropenic sepsis. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vinorelbine side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-10

Patient: 57 year old male

Reactions: Wrong Technique in Drug Usage Process, Neutropenic Sepsis, Skin Tightness, Incorrect Drug Administration Duration, Infusion Site Pain, Infusion Site Pruritus, Infusion Site Vesicles, Infusion Site Erythema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vinorelbine

Other drugs received by patient: Cisplatin



Possible Vinorelbine side effects in 75 year old female

Reported by a physician from United Kingdom on 2012-06-04

Patient: 75 year old female

Reactions: Haemoglobin Decreased, Haematocrit Decreased, Drug Ineffective, RED Blood Cell Count Decreased, Neutropenic Sepsis, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 7300 mg;;iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Rituximab (Rituximab)
    Dosage: 650 mg;; iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Neulasta
    Dosage: 6 mg; ; sc
    Indication: Prophylaxis
    Start date: 2011-06-15

Vinorelbine
    Dosage: 2 mg;;iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Doxorubicin HCL
    Dosage: 85 mg; ; iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Vincristine
    Dosage: 2 mg; iv;
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09



Possible Vinorelbine side effects in 75 year old female

Reported by a physician from United Kingdom on 2012-05-17

Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Neutropenic Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 85 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Neulasta
    Dosage: 6 mg, unk
    Indication: Prophylaxis
    Start date: 2011-06-15

Vinorelbine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Rituximab
    Dosage: 650 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Cyclophosphamide
    Dosage: 7300 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09



Possible Vinorelbine side effects in 75 year old female

Reported by a physician from United Kingdom on 2012-04-26

Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Neutropenic Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 85 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Neulasta
    Dosage: 6 mg, unk
    Indication: Prophylaxis
    Start date: 2011-06-15

Cyclophosphamide
    Dosage: 7300 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Vinorelbine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Rituximab
    Dosage: 650 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09



Possible Vinorelbine side effects in 65 year old female

Reported by a pharmacist from United Kingdom on 2012-04-26

Patient: 65 year old female

Reactions: Neutropenic Sepsis, Pancytopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: unk
    Indication: Lung Squamous Cell Carcinoma Stage Unspecified

Vinorelbine
    Dosage: unk
    Administration route: Oral
    Indication: Lung Squamous Cell Carcinoma Stage Unspecified

Other drugs received by patient: Domperidone



Possible Vinorelbine side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-04-26

Patient: 65 year old female

Reactions: Neutropenic Sepsis, Pancytopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: ;iv
    Indication: Squamous Cell Carcinoma

Vinorelbine
    Dosage: ;po
    Administration route: Oral
    Indication: Squamous Cell Carcinoma

Other drugs received by patient: Domperidone



Possible Vinorelbine side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-24

Patient: 65 year old female

Reactions: Neutropenic Sepsis, Pancytopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: week 1, cycle 2, intravenous (not otherwise specified)
    Indication: Lung Squamous Cell Carcinoma Stage Unspecified

Vinorelbine
    Dosage: week 2, week 3 off, oral
    Administration route: Oral
    Indication: Lung Squamous Cell Carcinoma Stage Unspecified

Other drugs received by patient: Domperidone



Possible Vinorelbine side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-20

Patient: 65 year old female

Reactions: Neutropenic Sepsis, Pancytopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vinorelbine
    Administration route: Oral

Carboplatin
    Dosage: unk
    Indication: Lung Squamous Cell Carcinoma Stage Unspecified

Other drugs received by patient: Domperidone



Possible Vinorelbine side effects in 75 year old female

Reported by a consumer/non-health professional from United Kingdom on 2012-04-18

Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Neutropenic Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vinorelbine
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-06

Neulasta
    Indication: Prophylaxis
    Start date: 2011-06-15

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09



Possible Vinorelbine side effects in 75 year old female

Reported by a physician from United Kingdom on 2012-04-18

Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Neutropenic Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 85 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Cyclophosphamide
    Dosage: 7300 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Rituximab
    Dosage: 650 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Vinorelbine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-06

Neulasta
    Dosage: 6 mg, unk
    Indication: Prophylaxis
    Start date: 2011-06-15



Possible Vinorelbine side effects in 75 year old female

Reported by a physician from United Kingdom on 2012-04-13

Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Neutropenic Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 7300 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Vinorelbine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Doxorubicin HCL
    Dosage: 85 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Rituximab
    Dosage: 650 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Neulasta
    Dosage: 6 mg, unk
    Indication: Prophylaxis
    Start date: 2011-06-15



Possible Vinorelbine side effects in 75 year old female

Reported by a physician from United Kingdom on 2012-03-28

Patient: 75 year old female

Reactions: White Blood Cell Count Decreased, Monocyte Count Decreased, Band Neutrophil Count Increased, Drug Ineffective, Neutropenic Sepsis, Monocyte Count Increased, Haemoglobin Decreased, Haematocrit Decreased, RED Blood Cell Count Decreased, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 85 mg; iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Cyclophosphamide
    Dosage: 7300 mg; iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-23
    End date: 2011-06-09

Vinorelbine
    Dosage: 2 mg; iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Neulasta
    Dosage: 6 mg; sc
    Indication: Prophylaxis
    Start date: 2011-06-15

Rituximab (Rituximab)
    Dosage: 650 mg; iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09



Possible Vinorelbine side effects in 75 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-26

Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Neutropenic Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 85 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Cyclophosphamide
    Dosage: 7300 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Rituximab
    Dosage: 650 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Vinorelbine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Other drugs received by patient: Neulasta



Possible Vinorelbine side effects in 71 year old female

Reported by a physician from United Kingdom on 2012-03-22

Patient: 71 year old female

Reactions: Klebsiella Infection, Pneumonia, Interstitial Lung Disease, Neutropenic Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Vinorelbine
    Indication: Adenocarcinoma
    Start date: 2009-09-01
    End date: 2009-10-01

Cisplatin
    Indication: Adenocarcinoma
    Start date: 2009-09-01
    End date: 2009-10-01



Possible Vinorelbine side effects in female

Reported by a physician from United Kingdom on 2012-03-22

Patient: female

Reactions: Neutropenic Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: code not broken
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-15

Blinded NO Treatment Received
    Dosage: code not broken
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-15

Vinorelbine
    Dosage: unk
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-15
    End date: 2011-12-29

Placebo
    Dosage: code not broken
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-15

Comparator Trastuzumab
    Dosage: unk
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-15

Diclofenac Sodium
    Indication: Pain

Vinorelbine
    Dosage: unk
    Start date: 2012-01-04



Possible Vinorelbine side effects in 75 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-19

Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Neutropenic Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 85 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Cyclophosphamide
    Dosage: 7300 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Rituximab
    Dosage: 650 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Vinorelbine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Other drugs received by patient: Neulasta



Possible Vinorelbine side effects in 75 year old female

Reported by a physician from Denmark on 2012-03-19

Patient: 75 year old female

Reactions: White Blood Cell Count Decreased, Monocyte Count Decreased, Band Neutrophil Count Increased, Drug Ineffective, Neutropenic Sepsis, Haemoglobin Decreased, Haematocrit Decreased, RED Blood Cell Count Decreased, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 7300 mg, iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Neulasta
    Dosage: 6 mg, sc
    Indication: Prophylaxis
    Start date: 2011-06-15

Rituximab (Rituximab)
    Dosage: 650 mg, iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Doxorubicin HCL
    Dosage: 85 mg, iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Vinorelbine
    Dosage: 2 mg,
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09



Possible Vinorelbine side effects in 75 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-13

Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Neutropenic Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vinorelbine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Doxorubicin HCL
    Dosage: 85 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Cyclophosphamide
    Dosage: 7300 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Rituximab
    Dosage: 650 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Other drugs received by patient: Neulasta



Possible Vinorelbine side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-13

Patient: 71 year old female

Reactions: Dyspnoea, Pneumonia Klebsiella, Interstitial Lung Disease, Neutropenic Sepsis, Cough

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: unk
    Indication: Adenocarcinoma
    Start date: 2009-09-01
    End date: 2009-10-01

Vinorelbine
    Dosage: unk
    Indication: Adenocarcinoma
    Start date: 2009-09-01
    End date: 2009-10-01



Possible Vinorelbine side effects in 75 year old female

Reported by a physician from United Kingdom on 2012-03-05

Patient: 75 year old female

Reactions: White Blood Cell Count Decreased, Haemoglobin Decreased, Haematocrit Decreased, RED Blood Cell Count Decreased, Drug Ineffective, Neutropenic Sepsis, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: 85 mg;iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Vinorelbine
    Dosage: 2 mg;iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Rituximab (Rituximab)
    Dosage: 650 mg;iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Neulasta
    Dosage: 6 mg;sc
    Indication: Prophylaxis
    Start date: 2011-06-15

Cyclophosphamide
    Dosage: 7300 mg;iv
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09



Possible Vinorelbine side effects in 75 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-29

Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Drug Ineffective, Neutropenic Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 7300 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Doxorubicin HCL
    Dosage: 85 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Vinorelbine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

Neulasta
    Dosage: 6 mg, unk
    Indication: Prophylaxis
    Start date: 2011-06-15

Rituximab
    Dosage: 650 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-05-24
    End date: 2011-06-09

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017